Skip to content

Wiser Choices in Acute Myocardial Infarction

Wiser Choices in Acute Myocardial Infarction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00888537
Enrollment
107
Registered
2009-04-27
Start date
2009-03-31
Completion date
2011-06-30
Last updated
2016-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction

Keywords

Decision aid, Heart attack, myocardial infarction

Brief summary

Patients who are hospitalized because of a heart attack are prescribed a number of medicines to help the heart heal. The investigators will examine different ways in which clinicians share information about those treatment options with patients and the impact that this can have on patients' choices and health.

Interventions

OTHERAMI Choice Decision Aid

The decision aid describes the risk of dying in the first six months following a heart attack without and with taking a bundle of medications to help the heart heal.

OTHERUsual Care

Patients and clinicians in this arm will discuss medications to help the heart heal after a heart attack in their usual manner.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Between the ages of 18 and 90 * Hospitalized at Saint Marys Hospital * A primary diagnosis of AMI, * Have heart rate, blood pressure, troponin and creatinine measurements, * There is an intention to offer treatment medications * Are able and willing to provide informed consent

Exclusion criteria

* Have not had a myocardial infarction * Have significant cognitive, visual impairment, * Non-English speaker * Have a Do Not Intubate/Do Not Resuscitate (DNI/DNR) status * Will be discharged to a nursing home * AMI is not the presumptive diagnosis

Design outcomes

Primary

MeasureTime frame
Increases adherence to cardiac medications with proven benefits6 months
Reduces patients' decisional conflict (increase patient decisional quality)During hospital stay
Decreases rehospitalization rates and death5 weeks and 6 months
Increase patient knowledge of medication to help the heart healDuring hospital stay

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026